Sanctuary Advisors LLC Increases Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Sanctuary Advisors LLC lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 25.5% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 64,754 shares of the medical equipment provider's stock after acquiring an additional 13,148 shares during the period. Sanctuary Advisors LLC's holdings in Intuitive Surgical were worth $31,812,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Great Valley Advisor Group Inc. raised its stake in Intuitive Surgical by 8.3% during the 2nd quarter. Great Valley Advisor Group Inc. now owns 2,477 shares of the medical equipment provider's stock worth $1,102,000 after buying an additional 189 shares during the period. ORG Partners LLC increased its holdings in shares of Intuitive Surgical by 3,411.1% during the second quarter. ORG Partners LLC now owns 316 shares of the medical equipment provider's stock valued at $138,000 after acquiring an additional 307 shares in the last quarter. Rockingstone Advisors LLC raised its position in shares of Intuitive Surgical by 0.5% during the second quarter. Rockingstone Advisors LLC now owns 8,748 shares of the medical equipment provider's stock worth $3,892,000 after purchasing an additional 41 shares during the period. Fiduciary Financial Group LLC bought a new position in shares of Intuitive Surgical in the 2nd quarter worth $394,000. Finally, Valley National Advisers Inc. grew its position in Intuitive Surgical by 29.3% in the 2nd quarter. Valley National Advisers Inc. now owns 622 shares of the medical equipment provider's stock valued at $276,000 after purchasing an additional 141 shares during the period. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Performance

NASDAQ:ISRG traded up $1.12 during midday trading on Thursday, reaching $544.72. 1,211,159 shares of the stock traded hands, compared to its average volume of 1,441,064. The stock has a market capitalization of $194.02 billion, a P/E ratio of 87.40, a PEG ratio of 5.41 and a beta of 1.38. The company has a fifty day moving average of $519.37 and a 200 day moving average of $477.06. Intuitive Surgical, Inc. has a 12 month low of $320.22 and a 12 month high of $556.23.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The firm had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. On average, analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research firms have weighed in on ISRG. Robert W. Baird raised their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an "outperform" rating in a research note on Thursday, October 17th. Truist Financial raised their price target on shares of Intuitive Surgical from $520.00 to $570.00 and gave the company a "buy" rating in a research report on Monday, October 14th. Morgan Stanley raised Intuitive Surgical from an "equal weight" rating to an "overweight" rating and boosted their price objective for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. Raymond James raised their target price on Intuitive Surgical from $500.00 to $540.00 and gave the company an "outperform" rating in a report on Monday, October 14th. Finally, Evercore ISI reiterated a "cautious" rating on shares of Intuitive Surgical in a report on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $550.28.

Insider Buying and Selling

In other news, CEO Gary S. Guthart sold 18,151 shares of the company's stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the transaction, the chief executive officer now directly owns 24,219 shares of the company's stock, valued at $12,391,166.97. This represents a 42.84 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Amy L. Ladd sold 450 shares of the company's stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $490.28, for a total transaction of $220,626.00. Following the transaction, the director now owns 821 shares in the company, valued at $402,519.88. This represents a 35.41 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 48,640 shares of company stock valued at $25,233,553 over the last ninety days. Company insiders own 0.90% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.